Treating common psychiatric disorders associated with attention-deficit/hyperactivity disorder
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Attention-deficit/hyperactivity disorder (ADHD) often occurs along with other psychiatric disorders, with estimated comorbidity rates of 50--90%. Comorbidity greatly influences presentation, diagnosis and prognosis, complicates treatment and significantly increases the morbidity and disease burden of ADHD. Commonly co-occurring psychiatric disorders are disruptive behavior disorder, anxiety, depression, bipolar disorder and substance use disorders. This article provides a brief review of effective strategies for treating the most common psychiatric disorders associated with ADHD. This paper also discusses knowledge gaps in the understanding of treatment of comorbid disorders associated with ADHD, and directions for future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
Mannuzza, S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820190067007 · Cited by 1,368
ADHD Comorbidity Findings From the MTA Study: Comparing Comorbid Subgroups
JENSEN, P. S., HINSHAW, S. P., KRAEMER, H. C., LENORA, N., NEWCORN, J. H., ABIKOFF, H. B., MARCH, J. S., ARNOLD, L. E., CANTWELL, D. P., CONNERS, C. K., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00009 · Cited by 974 · cited 1×
“The co-occurrence of ADHD and anxiety disorders in children is common, with estimated comorbidity rates of 20 – 40% [2,17].”
BackgroundGELLER, B., COOPER, T. B., SUN, K., ZIMERMAN, B., FRAZIER, J., WILLIAMS, M., & HEATH, J. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199802000-00009 · Cited by 526
BIEDERMAN, J., WILENS, T., MICK, E., FARAONE, S. V., WEBER, W., CURTIS, S., THORNELL, A., PFISTER, K., JETTON, J. G., & SORIANO, J. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199701000-00013 · Cited by 476
Self-citationWILENS, T. E., BIEDERMAN, J., BROWN, S., TANGUAY, S., MONUTEAUX, M. C., BLAKE, C., & SPENCER, T. J. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200203000-00005 · Cited by 391 · cited 2×
“Studies have shown that 30 – 50% of children with ADHD are likely to have another externalizing, disruptive behavior disorder, with oppositional defiant disorder (ODD) being two- to threefold more common than conduct disorder (CD) [1,5].”
BackgroundKOWATCH, R. A., SUPPES, T., CARMODY, T. J., BUCCI, J. P., HUME, J. H., KROMELIS, M., EMSLIE, G. J., WEINBERG, W. A., & RUSH, A. J. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200006000-00009 · Cited by 389
Pelham, W. E., Gnagy, E. M., Burrows-Maclean, L., Williams, A., Fabiano, G. A., Morrisey, S. M., Chronis, A. M., Forehand, G. L., Nguyen, C. A., Hoffman, M. T., et al. (2001) · Pediatrics · doi:10.1542/peds.107.6.e105 · Cited by 378 · cited 1×
“Stimulants not only treat ADHD symptoms, they also improve the behavioral difficulties associated with both ODD and CD, and improve overall quality of life [6-9].”
BackgroundKlein, R. G. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830240023003 · Cited by 349 · cited 2×
“Consistent with other studies [6], this trial also demonstrated that stimulant treatment in children with ADHD and comorbid anxiety leads to ADHD symptom reductions similar to those seen in non-comorbid ADHD; and also showed that stimulants are tolerated without significant exacerbation of anxiety or development of un…”
BackgroundResultCONNOR, D. F., GLATT, S. J., LOPEZ, I. D., JACKSON, D., & MELLONI, R. H. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200203000-00004 · Cited by 333
Effect of Anxiety on Cognition, Behavior, and Stimulant Response in ADHD
PLISZKA, S. R. (1989) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198911000-00012 · Cited by 293 · cited 1×
“There has been ongoing concern that stimulants may be associated with more side effects and a less robust response in patients with ADHD that is comorbid with an anxiety disorder compared with ADHD alone [19].”
BackgroundScheffer, R. E., Kowatch, R. A., Carmody, T., & Rush, A. J. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.58 · Cited by 260 · cited 1×
“There is one placebo-controlled study of mixed amfetamine salts that was shown to be effective for the treatment of ADHD symptoms in a pediatric population with BPD whose symptoms had been stabilized with mood stabilizers [48].”
BackgroundSchubiner, H., Downey, K. K., Arfken, C. L., Johanson, C.-E., Schuster, C. R., Lockhart, N., Edwards, A., Donlin, J., & Pihlgren, E. (2002) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.10.3.286 · Cited by 249
Newcorn, J. H., Spencer, T. J., Biederman, J., Milton, D. R., & Michelson, D. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200503000-00008 · Cited by 174 · cited 1×
“The newer nonstimulant treatment for ADHD, atomoxetine, has been shown to improve symptoms of comorbid ODD in children with ADHD [10,11]; it has not been studied in ADHD with comorbid CD.”
BackgroundSULLIVAN, M. A., & RUDNIK‐LEVIN, F. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05783.x · Cited by 172
Kratochvil, C. J., Newcorn, J. H., Arnold, L. E., Duesenberg, D., Emslie, G. J., Quintana, H., Sarkis, E. H., Wagner, K. D., Gao, H., & Michelson, D. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000169012.81536.38 · Cited by 152 · cited 2×
“, discussed above [23]) that compares atomoxetine monotherapy with atomoxetine combined with fluoxetine in children with ADHD and comorbid mood or anxiety symptoms.”
BackgroundCorrelates of ADHD among children in pediatric and psychiatric clinics
Busch, B., Biederman, J., Cohen, L. G., Sayer, J. M., Monuteaux, M. C., Mick, E., Zallen, B., & Faraone, S. V. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.9.1103 · Cited by 147 · cited 1×
“Similar high rates of psychiatric comorbidity have been found in psychiatric, as well as pediatric, patient populations [3].”
BackgroundSelf-citationResponse to Methylphenidate in Children With ADHD and Comorbid Anxiety
DIAMOND, I. R., TANNOCK, R., & SCHACHAR, R. J. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199904000-00012 · Cited by 132
Riggs, P. D., Hall, S. K., Mikulich-Gilbertson, S. K., Lohman, M., & Kayser, A. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200404000-00008 · Cited by 89 · cited 1×
“In this study the use of pemoline was effective for ADHD, but did not have an effect on CD or substance abuse in the absence of specific treatment for substance abuse disorder [55].”
BackgroundHah, M., & Chang, K. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.996 · Cited by 48
Cited by
Yoshimasu, K., Barbaresi, W. J., Colligan, R. C., Voigt, R. G., Killian, J. M., Weaver, A. L., & Katusic, S. K. (2012) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2012.02567.x · Cited by 290
Developmental comorbidity in attention-deficit/hyperactivity disorder
Taurines, R., Schmitt, J., Renner, T., Conner, A. C., Warnke, A., & Romanos, M. (2010) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-010-0040-0 · Cited by 198
Pozzi, M., Carnovale, C., Peeters, G. G. A. M., Gentili, M., Antoniazzi, S., Radice, S., Clementi, E., & Nobile, M. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.05.021 · Cited by 56
Andreasen, J. T., Redrobe, J. P., Nielsen, E. Ø., Christensen, J. K., Olsen, G. M., & Peters, D. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.060 · Cited by 15
Metadata
- Authors
- Kunwar, A., Dewan, M., & Faraone, S. V.
- Venue
- Expert Opinion on Pharmacotherapy
- Publisher
- Informa Healthcare
- Published
- 2007-03-22
- Volume
- 8
- Issue
- 5
- Pages
- 555-562
- ISSN
- 1465-6566 (ISSN-L)
- 1744-7666
- OpenAlex
- W2138058758
- Cited by
- 45
- References
- 20
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.